anodic solution was a 40 mM aspartic acid. First-dimensional IEF was conducted at 4 mA and 600 V for 20 h at 15°C. Afterward the proteins in the gel were fixed with the protein fixing solution containing 10% trichloroacetic acid and 5% sulfosalicylic acid for 1 h at room temperature. Then, the agarose gel was washed with distilled water for 1 h.
Second Dimensional Electrophoresis The first-dimensional agarose IEF gels were loaded on the top of the slab gel and covered with 1% agar solution to keep the agarose IEF gels in place. Then, 1.5 ml of SDS buffer was overlaid on the IEF gels. The second-dimensional electrophoresis was conducted at 120 mA and 250 V until the end of the run. The slab gels were first soaked and shaken overnight in a destaining solution containing 30% methanol and 10% acetic acid, which removed Pharmalytes from the gel. They were then stained with CBB and destained with the destaining solution.
Image Analysis of 2D-PAGE The CBB stained gels were scanned and the data was analyzed using a Molecular Imager Fx (Bio-Rad, CA, U.S.A.).
N-Terminal Amino Acid Sequence Analysis 2D-PAGE separated proteins were electroblotted onto a polyvinylididene difluoride (PVDF) membrane (MilliPore). The membrane was washed in deionized water for 5 min, stained with 0.25% CBB in 30% methanol, 7.5% acetic acid for 5 min, and then destained in 30% methanol and 7.5% acetic acid at room temperature. The proteins were excised from the PVDF membrane, destained in 100% methanol for a few seconds, rinsed in deionized H 2 O for 10 min, rinsed in 100% methanol for a few seconds, air dried, and finally stored at Ϫ20°C. The N-terminal amino acid sequences were identified by a Procise TM HT protein sequencing system (Applied Biosystems) and compared with protein sequences in the Swiss-Prot database using the FASTA sequence alignment program.
Mass Spectrometry Analysis The CBB stained protein spots were excised from the gel and destained with 50% CH 3 CN in 50 mM NH 4 HCO 3 for 1 h at room temperature. After the gel pieces were dehydrated with 100% CH 3 CN, the liquid was removed, and the pieces were dried in a Speed Vac. Next, they were reduced with 10 mM DTT in 100 mM NH 4 HCO 3 for 45 min at 56°C and incubated with 55 mM iodoacetamide 100 mM NH 4 HCO 3 for 30 min at room temperature in the dark. After the liquid was removed, the gel slices were washed with 50% CH 3 CN, dehydrated with 100% CH 3 CN, rehydrated with 100 mM NH 4 HCO 3 , dehydrated with 100% CH 3 CN, and dried in a Speed Vac. After absorption of the protease solution (12.5 ng/ml trypsin in 50 mM NH 4 HCO 3 ) for 45 min at 4°C, 50 mM NH 4 HCO 3 was added until the gel pieces recuperated their original size. They were then left over night at 37°C. After the reaction, the peptide fragments were extracted from the gels by sonication in 50% CH 3 CN containing 5% HCOOH for 20 min. The pooled liquids were evaporated in a Speed Vac, and the samples dissolved in 10 ml of 0.1% trifluoroacetic acid (TFA) in 50% CH 3 CN. The peptide extract was desalted and concentrated using Zip Tips C18 from Millipore (Bedford, MA, U.S.A.) following the manufacture's instructions.
MALDI-TOF-MS was measured by a QSTAR-Pulser-i equipped with oMALDI ion source (Applied Biosystems) or AXIMA-CFR (Shimadzu Corp.). A saturated solution of acyano-4-hydroxycinnamic acid (1 ml) at 2 mg/200 ml in 50% CH 3 CN containing 0.1% TFA was mixed with 1 ml of peptide solution on the MALDI target and left to dry. LC/MS/MS was measured by an MAGIC 2002 HTC-PAL LC-Q advantage (ThermoQuest, Tokyo). The peptide mass fingerprint obtained for each protein digest was compared with protein sequences in the Swiss-Prot and NCBI database using Mascot software (Matrix Science Ltd., London, U.K.).
Quantification of Gene Expression by the Real-Time Quantitative PCR RNA was prepared from cells using QI-AGEN (Tokyo) Mini RNA-easy kit. The reverse transcription was performed from 1 mg RNA in 20 ml reaction according to the manufacture's instructions (Takara RNA PCR kit). PCR amplification and analysis were achieved using real time PCR (PRISM 7000, Applied Biosystem, CA, U.S.A.). cDNA (5 ml) obtained by the reverse transcription reaction, 0.5 mM of each primers, 25 ml SYBR Green Master Mix (Applied Biosystems, CA, U.S.A.) in a total volume of 50 ml. cDNA denatured by a pre-incubation for 10 min at 95°C and the template was amplified for 40 cycles of denaturation for 15 s at 95°C, annealing of primers and extension at 63°C for 15 s. Standard curves were generated from cDNAs made from increasing amounts of total RNA (1.6, 8, 40, 200, 1000 ng) using GAPDH primers. The threshhold cycle (Ct) was determined with the use of the quantification software (Version 1.7; Applied Biosystem). RT-PCR was performed using oligo(dT) 30 primer and total RNA (0.5 mg) for first strand cDNA synthesis. PCR reactions were carried out at 94°C for 1 min, 60°C for 1 min, 72°C for 1 min and 25 amplification cycles. The primer sequences are shown in Table  3 .
RESULTS

Changes in the Protein Pattern in FAK-Transfected HL-60 Cells
To detect the proteins related to antiapototic activity in HL-60/FAK cells, we performed 2D-PAGE analysis on the extracts from HL-60 parent, HL-60/Vect and HL-60/FAK cells. As illustrated in Fig. 1A , 2D-PAGE of HL-60 parent and HL-60/Vect cells was almpost the same pattern. A large number of protein spots (ca. 300) were separated on 2D-PAGE gel stained with CBB. Approximately 10% of them showed up-or down-regulation in their expression levels in HL-60/FAK cells as compared to HL-60/Vect cells. Among them, 12 proteins (numbers 5-16) that were up-regulated and 3 proteins (numbers 1-3) that were down-regulated (Table 1) were identified. The expression of FAK (number 4) in HL-60/FAK cells was confirmed by Western blotting as shown in Fig. 1B .
Identification of the Proteins Modulated by FAK Overexpression
Proteins showing modulations in their expression level were subjected to N-terminal amino acid sequence analysis after blotting, and the sequences of them were determined. These sequences were compared with protein sequences in the SWISS-PROT databases using FASTA. Six proteins were identified: hsp90b, nucleolin, 60S ribosomal protein L6, 60S ribosomal protein L8, 40S ribosomal protein S4X, and 60S ribosomal protein S8. Proteins unidentified by N-terminal amino acid sequence analysis were subjected to MALDI/TOF/MS or LC/MS/MS analysis after digestion. The peptide masses (MS) obtained were compared with the MS of the predicted tryptic peptides from theoretical masses from the NCBI and SWISS-PROT databases using Mascot.
Six up-regulated proteins were identified as hsp70-4, hsp70-1B, elongation factor Tu (EF-Tu), laminin receptor, peroxiredoxin 2, and glyoxalase 1. Hsp70-4, EF-Tu, and the laminin receptor were identified by MALDI/TOF/MS, and Hsp70-1B peroxyredoxin 2, and glyoxalase 1 were identified by LC/MS/MS. Three down-regulated proteins were identified as pyruvate kinase M2, protein disulfideisomerase, and Rho GDP dissociation inhibitor (GDI) 2. pyruvate kinase M2 and protein disulfide isomerase were identified by MALDI/TOF/MS, and Rho-GDI 2 was identified by LC/MS/MS. Table 1 shows that the name of identified proteins, accession number from the SWISS-PROT data base, the experimental pI and molecular weight (MW), the theoretical pI and MW, the identification method, N-terminal amino acid or representative sequences peptide identified by MALDI/TOF/MS or LC/MS/MS. Table 2 shows the major functions of identified proteins.
mRNA Expression of Proteins Identified with 2D-PAGE Real-time PCR analysis except for ribosomal proteins was performed using the primers listed in Table 3 . The results for protein disulfide isomerase, Rho-GDI 2, pyruvate kinase M2, HSP70-1B, HSP70-4, HSP90b, laminin receptor, peroxyredoxin 2, glyoxalase 1, nucleolin, and EF-Tu are shown in Fig. 2 . The expressions of mRNA for HSP70-1B, HSP70-4, HSP90b, laminin receptor, peroxyredoxin 2 and glyoxalase 1 were increased in HL-60/FAK cells. In contrast, the expressions of disulfide isomerase and Rho-GDI 2 were decreased in HL-60/FAK cells. The changes of mRNA levels of these proteins were correlated with those of the protein expression. However, the changes of mRNA levels of pyruvate kinase M2, nucleolin and EF-Tu were not correlated with those of the protein expression. These results indicate that the posttranscriptional regulation might have occurred in these proteins. Further experiments are needed to explore in more detail.
Induction of the Thioredoxin System in HL-60/FAK Cells As shown in Figs. 1 and 2, we detected an increase in peroxyredoxin 2 by 2D-PAGE analysis in HL-60/FAK cells. The overexpression of peroxyredoxin 2 occurs in several cancers and is related to resistance to apoptosis induced by radiation therapy or the anti-cancer drug, cisplatin. 11) Peroxyredoxins include at least six isoforms peroxyredoxins 1 to 6. 12) Although peroxyredoxins are primarily located in the cytosol, they are also found within the mitochondoria, nucleus and membranes. Many cells produce more than one isoform of peroxyredoxins, we examined the expression of peroxyredoxins 1 to 6 by real time-PCR. As shown in Fig. 3 , peroxyredoxins except for peroxyredoxin 3 and 6 were increased in HL-60/FAK cells. The expression of peroxiredoxin 4 was increased by the treatment with 0.1 mM H 2 O 2 in both cells. The expressions of the other peroxyredoxin mRNAs did not change by the treatment with 0.1 mM H 2 O 2 . Peroxyredoxins exist as homodimers and catalyze the reduction of H 2 O 2 by using thioredoxin cycle containing thioredoxin, thioredoxin reductase, and peroxyredoxin. 13) To determine whether the mRNA levels of these proteins involved in the thioredoxin cycle were enhanced, we examined their expression by realtime PCR. As shown in Fig. 3 , mRNA levels of thioredoxin reductase 1-3 were increased in HL-60/FAK cells. By the treatment with 0.1 mM H 2 O 2 , thioredoxin reductasae 1 and 2 did not change, but thioredoxin reductase 3 was decreased. While basal thioredoxin 1 and 2 mRNA levels were not different between HL-60/Vect and HL-60/FAK cells, they were decreased in HL-60/Vect cells but not in HL-60/FAK cells after exposure to 0.1 mM hydrogen peroxide. Of interest is that the decrease of thioredoxin 1 and 2 mRNA was minimal in HL-60/FAK treated with 0.1 mM H 2 O 2 , while the decrease in HL-60/Vect cells were marked. Thus, these results suggest that thioredoxin cycle is activated in HL-60/FAK cells.
DISCUSSION
In this study, we found that in HL-60/FAK cells, the expression of proteins concerned with protein synthesis, antioxidant enzymes and signal transduction were changed. Since HL-60/FAK cells grow faster than the HL-60/Vect cells, 14) it is possible that ribosomal proteins such as 60S ribosomal protein L6, 40S ribosomal protein S4X, 60S ribosomal protein L8, and 40S ribosomal protein S8 were changed. The experimental pI of these ribosomal proteins were different from the theoretical pI of them, ca. 10-11. They may be modified by the posttranslational processing conferring additional negative (acidic) charge such as phosphorylation. EF-Tu is also required for protein synthesis, in which the mRNA codon in the ribosomal A-site is recognized by aminoacyl-tRNA in a ternary complex with EF-Tu and GTP. 15) Antioxidants govern the intracellular redox status. Inside cells, glutathione, and thioredoxin are the major reducing agents. Thioredoxin, thioredoxin reductase, and peroxyredoxin (thioredoxin peroxidase) are three linked components in a redox chain that couples peroxide reduction to NADPH oxidation. 16 ) Peroxyredoxins 1-6 belong to a cysteine-containing antioxidant family of proteins which have been identified in a wide variety of organisms. 17 Plays a role in detoxification of methylglyoxal, a side product of glycolysis 
apoptosis. 18) These results suggest that peroxyredoxins 2 might confer cancer cells with chemoresistance or radioredistance. This resistance is derived from the elimination of hydrogen peroxide produced by cisplatin or radiation treatment. The introduction of peroxyredoxin 2 antisense DNA facilitates cisplatin-induced cell death. 19) Thus, drugs that down-regulate peroxyredoxin 2 could be new drug targets for the cancer treatment. Therefore, the increase in peroxyredoxin 2 in HL-60/FAK cells is intriguing. Recently, we demonstrated that basal activity and mRNA expression of glutathione reductase and phospholipid hydroperoxide glutathione peroxidase were markedly elevated in in HL-60/FAK cells. 20) These results suggest that FAK up-regulates protein of glutathione cycle and thioredoxin cycle. Glyoxalase 1 is involved in the detoxification of methylglioxal, a side product of gycolysis, which is highly reactive with DNA and proteins. Glyoxalase 1 activity is elevated in prostate cancer than in non-cancerous specimens, which suggests a relationship between Glyoxalase 1 and cell viability. 21) Nucleolin is a major nucleolar protein found in exoponentially growing eukaryotic cells, and is involved in the regulation of ribosome biogenesis and maturation. Numerous reports have implicated the involvement of nucleolin in the regulation of cell proliferation and growth. 22) In addition, nucleolin may play a role in removing cleaved PARP-1 from dying cells. 23) The laminin receptor takes part in the mediation of multidrug resistance in gastric cancer cells by interferring with drug accumulation and cell apoptosis. 24) Heat-shock proteins (HSPs) are ubiquitous and highly conserved proteins whose expression is induced in response to a wide variety of physiological and environmental stresses. Several HSPs have been found to interact with various components of the programmed cell death machinery and play a role in the proteasome-mediated degradation of client proteins. 25) Unlike the more general HSP70 and HSP60 chaperones, HSP90 has substrate-specific folding activity and regulates the conformation of signal transduction molecules such as steroid hormone receptor, and some kinases. HSP90 inhibits apoptosis by suppressing the cytochrome c-mediated oligomerization of Apaf-1 or by stabilizing Akt kinase activity. Hsp90 is an essential cytosolic protein and its overexpression in a wide variety of malignant tumors makes it a target for pharmacological intervention. 26) The disruption of these heterocomplexes by hsp90 inhibitors causes the rapid degradation of hsp90-client proteins by the proteasome. Previous reports showed an association between hsp90 and FAK stabilization. 27) We observed that hsp90 inhibitor decreased the level of expression of phosphorylated FAK in HL-60/FAK cells in a dose-dependent manner (data not shown).
Pyruvate kinase M2 plays a role in the glycolytic pathway. At present, little is known about the relationship between apoptosis and glycolysis. Recently, Yoo et al. reported that Pyruvate kinase M2 shows lower expression in cisplatin-resistent cells compared to the parental cells, SNU-638. 28) This data suggests an association between pyruvate kinase M2 and apoptosis-resistant cells.
Protein disulfide isomerase is a multifunctional protein that catalyzes the formation of disulfide bonds. It also acts as a molecular chaperone and is a component of the enzyme prolyl 4-hydroxylase and microsomal triglyceride transfer protein. 29) Although Protein disulfide isomerase was decreased in HL-60/FAK cells, the reason for this is unclear.
Rho-GDI is involved in the regulation of integrin activity and in the organizing of the actin cytoskeleton. 30) The Rho-GDI family consists of three members, Rho-GDI-1, 2, 3. Rho-GDI 1 is ubiquitously expressed, whereas Rho-GDI 2 is expressed in haemopoietic cells and Rho GDI-3 in the brain, lung, kidneys, testis and pancreas. 31) The cleavage of Rho-GDI 2 occurrs with the activation of caspase-3 during Fas-induced apoptosis, but not for Rho-GDI 1. 32) Furthermore, Rho-GDI 2 deficiency decreases IL-2-withdrawal induced apoptosis in lymph node cells while dexamethazone-and Tcell receptor-induced apoptosis remains intact. These results show that Rho-GDI 2 is associated with lymphocyte survival. 33) In conclusion, we first found that FAK overexpression induces antiapoptotic enzymes, hsp90, peroxyredoxin 2, glyoxalase 1 and decreases Rho-GDI 2. These proteins could contribute to defense against apoptosis. The expression of thioredoxin and peroxyredoxin 1 is regulated by phosphatydylinositol kinase and transcription factor Nrf2. 34) Further studies are needed to clarify the mechanism responsible for changing protein expression as seen in this study.
